These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26390962)

  • 1. What can we do about exploratory analyses in clinical trials?
    Moyé L
    Contemp Clin Trials; 2015 Nov; 45(Pt B):302-310. PubMed ID: 26390962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive design of confirmatory trials: Advances and challenges.
    Lai TL; Lavori PW; Tsang KW
    Contemp Clin Trials; 2015 Nov; 45(Pt A):93-102. PubMed ID: 26079372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive design in clinical research: issues, opportunities, and recommendations.
    Chang M; Chow SC; Pong A
    J Biopharm Stat; 2006 May; 16(3):299-309; discussion 311-2. PubMed ID: 16724486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the simulation in the clinical investigation].
    Monleón-Getino T
    Med Clin (Barc); 2013 Dec; 141(12):550-5. PubMed ID: 24238627
    [No Abstract]   [Full Text] [Related]  

  • 5. Adaptive methods: when and how should they be used in clinical trials?
    Porcher R; Lecocq B; Vray M;
    Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model averaging for treatment effect estimation in subgroups.
    Bornkamp B; Ohlssen D; Magnusson BP; Schmidli H
    Pharm Stat; 2017 Mar; 16(2):133-142. PubMed ID: 27935199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
    Hemmings R
    J Biopharm Stat; 2014; 24(1):4-18. PubMed ID: 24392975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian models for subgroup analysis in clinical trials.
    Jones HE; Ohlssen DI; Neuenschwander B; Racine A; Branson M
    Clin Trials; 2011 Apr; 8(2):129-43. PubMed ID: 21282293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple imputation techniques in small sample clinical trials.
    Barnes SA; Lindborg SR; Seaman JW
    Stat Med; 2006 Jan; 25(2):233-45. PubMed ID: 16220515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robustness considerations in Bayesian analysis.
    Gustafson P
    Stat Methods Med Res; 1996 Dec; 5(4):357-73. PubMed ID: 9004378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring in clinical trials: benefit or bias?
    Nardini C
    Theor Med Bioeth; 2013 Aug; 34(4):259-74. PubMed ID: 23824468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bayesian interpretation of a P-value depends only weakly on statistical power in realistic situations.
    Hooper R
    J Clin Epidemiol; 2009 Dec; 62(12):1242-7. PubMed ID: 19398295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating statistics in clinical trials: making the unintelligible intelligible.
    Gilmore SJ
    Australas J Dermatol; 2008 Nov; 49(4):177-84; quiz 185-6. PubMed ID: 18855776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician.
    Chertow GM; Palevsky PM; Greene T
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1124-7. PubMed ID: 17699335
    [No Abstract]   [Full Text] [Related]  

  • 16. Statistical decisions and the interim analyses of clinical trials.
    Stanev R
    Theor Med Bioeth; 2011 Feb; 32(1):61-74. PubMed ID: 21222041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim analyses in clinical trials.
    Emerson SS; Fleming TR
    Oncology (Williston Park); 1990 Mar; 4(3):126-33; discussion 134, 136. PubMed ID: 2144441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A local influence sensitivity analysis for incomplete longitudinal depression data.
    Shen S; Beunckens C; Mallinckrodt C; Molenberghs G
    J Biopharm Stat; 2006 May; 16(3):365-84. PubMed ID: 16724491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian statistical methods in public health and medicine.
    Etzioni RD; Kadane JB
    Annu Rev Public Health; 1995; 16():23-41. PubMed ID: 7639872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials within trials: confirmatory subgroup analyses in controlled clinical experiments.
    Moyé LA; Deswal A
    Control Clin Trials; 2001 Dec; 22(6):605-19. PubMed ID: 11738119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.